-
Affected by Hurricane Maria, Haizheng Pharmaceuticals is back out of stock
Time of Update: 2021-02-27
in late May 2018, Hanyu Pharmaceuticals received notification from Pfizer that its Puerto Rico plant had been severely damaged by Hurricane Maria late last year, resulting in a degree of supply constraints for Refinan finished products in the Chinese market.
-
Murray Medical's first day of trading jumped 44% market value is expected to impact the "GEM brother"
Time of Update: 2021-02-27
Then the in-market stop, after the resumption of trading, Murray Medical quickly closed, as of the close, the company's share price jumped 44% to close at 70.27 yuan / share, a total market value of 85.427 billion yuan.
-
Beda Pharmaceuticals listed two years of continuous decline in performance, trapped in the "one drug, one big" dilemma?
Time of Update: 2021-02-27
third-quarter results showed that Bayda Pharmaceuticals reported revenue of 928 million yuan in the first three quarters, up 20.74 percent from a year earlier, while net profit attributable to shareholders of listed companies was 148 million yuan, down 27.37 percent from a year earlier.
-
The world's market capitalization of more than a trillion dollars Apple layout medical speed up
Time of Update: 2021-02-27
Apple shares were trading at $207.39 in the early hours of August 3, Beijing time, with a market capitalisation of $101.678 billion.
-
Zixin Pharmaceuticals' performance surged to 5.2 billion inventory shadow financial fraud doubts
Time of Update: 2021-02-27
- Huaxin Trust Value Return No. 2 Securities Investment Pooled Fund Trust Plan held 16.262 million shares at the end of the first half of the year, accounting for 1.586 percent of the outstanding shares, in the third quarter has been withdrawn from the top ten outstanding shareholders.
-
One heart into a retail chain pharmaceutical industry leader Chairman is optimistic about the big health
Time of Update: 2021-02-27
Yunnan listed company Yunnan Hongxiang One Heart Tang Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as: One Heart Hall) recently because of three things in the listed company's pharmaceuti
-
Changsheng Bio's vice chairman was sued by Societe Generale for 630 million yuan
Time of Update: 2021-02-27
July 23rd, ST Changsheng announced that Zhang hao, a shareholder of the company, had made three supplementary pledges for his 73.3624 million shares, with the rights per capita being Henyep Securities.
-
Lepu Medical: mergers and acquisitions more than 30 times only to set up a "heart" of hope
Time of Update: 2021-02-27
Lepu Medical took several years of extended mergers and acquisitions to acquire the cardiovascular field of overweight pounds, heavy weights, sub-segmented leading drugs, from the technical and market dimensions, to further build a "moth." fully biodegradable vascular stent (NeoVas) is a technological revolution in the field of cardiovascular interventional therapy at Lepu Medical.
-
Hong Kong Special Administrative Region Government: The kosing vaccine is approved for emergency use in accordance with regulations
Time of Update: 2021-02-24
THE SAR Government means that the advisory committee's examination of the data and the Government's approval process is rigorous, comprehensive and meets the relevant requirements under all the Regulations, which is no different from the procedure for approving the previous new crown vaccine approved for emergency use in Hong Kong.
-
Biosynthic drug policy landing: can not automatically extratrot reference drug all adaptive
Time of Update: 2021-02-24
February 19th, February 18th, the first working day after the National Drug Administration Drug Review Center (CDE) official website issued the "Biosyspole Drug Similarity Evaluation and Adaptation Ex
-
From drug-free to multiple treatments, 34 clinically urgently needed new drugs have been approved
Time of Update: 2021-02-24
addition, NMPA has approved a number of clinically urgent overseas drugs to bring innovative therapies to patients with multiple types of diseases.
-
General Administration of Market Supervision: Third-party nucleic acid testing institutions may not use service packages and other means to force bundle charges
Time of Update: 2021-02-24
Pharmaceutical Network February 8th, February 7th, the General Office of the General Administration of Market Supervision announced the "Notice on doing a good job in the near-term price supervision c
-
Latest! The price of Chinese medicine is generally rising, and the quality is improving
Time of Update: 2021-02-24
Industry generally believe that in the short term, the implementation of the new pharmacopeia may stimulate the price of Chinese herbal medicines, but in the long run, more stringent quality standards, will undoubtedly regulate the entire Chinese herbal medicine market more healthy development.
-
The State Department has issued new rules on health care! These acts should be severely punished!
Time of Update: 2021-02-24
On February 20th, the Chinese government issued the Regulations on the Supervision and Administration of the Use of Medical Security Funds (hereinafter referred to as the Regulations on Administration
-
Lilly and Rigel have agreed to a $960 million RIPK1 inhibitor partnership
Time of Update: 2021-02-24
On Thursday, Lilly announced an exclusive licensing agreement with Rigel Pharmaceuticals, in which the two companies will jointly develop Rigel's RIPK1 inhibitor R552 and will be responsible for the commercialization of the therapy for all adaptations, including autoimmune and inflammatory diseases.
-
Tiansli chlor nitrogen flat tablets are evaluated by generic consistency
Time of Update: 2021-02-24
date of this announcement, Jiangsu Diyi has invested approximately RMB 827.8 million in research and development for the drug's consistency evaluation.
-
Biopharmaceonceons with volume procurement approaching
Time of Update: 2021-02-24
On January 28 this year, the State Council issued the Opinions on Promoting the Normal institutionalization of drug centralized belt procurement, which requires that "the clinically necessary and reli
-
Why is it so difficult to register? Online medical appointments to prevent "Yellow" rob number
Time of Update: 2021-02-24
Medical Network February 8th, Ms. Zhou, a reader living in a central city, recently wrote a letter about her troubles. , she had a stomach atrial condition and went to a local hospital, where her cond
-
Heavy! The State Council issued a good document on the interests of Chinese medicine and respected the law of research and development of Chinese medicine
Time of Update: 2021-02-24
(The State Administration of Traditional Chinese Medicine, the National Development and Reform Commission, the National Health And Health Commission, the Ministry of Industry and Information Technology, the State Drug Administration is responsible for) to improve the Western medicine study of Chinese medicine system from 2021, the Chinese medicine curriculum as a compulsory undergraduate clinical medicine major and graduation internship content, increase the course time.
-
Coxing Zhongwei's new crown inactivated vaccine has been approved for sale in China
Time of Update: 2021-02-24
11 January, the Indonesian Drug and Food Administration announced that it had granted emergency approval for the vaccine.
